Start-Up Tailors AI-Designed Phage to Treat Resistant Infection

A start-up reports using AI-designed bacteriophages to treat a patient with an antibiotic-resistant infection, claiming a tailored virus cleared the illness. The claim is based on a single case study, with efficacy and safety unverified beyond the company's report. This marks a potential first in AI-driven phage therapy, but independent corroboration is lacking.